OP-055 The First Real-World Experience of the New Oral Anticoagulants in Turkey

According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointesti...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2016-06, Vol.117, p.S22-S23
Main Authors: Yiginer, Omer, Erdal, Emrah, Acar, Gurkan, Cay, Serkan, Ergelen, Mehmet, Cetin, Hande, Tezcan, Mehmet, Dogan, Mehmet, Un, Haluk, Ozcelik, Fatih, Degirmencioglu, Gokhan, Tokatli, Alptug
Format: Article
Language:English
Subjects:
Anticoagulants
Cardiovascular
Coagulation
Hemorrhage
Thromboembolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:According to this data, both drugs has no superiority over each other in terms of the protection from thromboembolism and hemorrhagic complications. All Cause Death 10 5 n.s. Thromboembolism 0 1 (cerebrovascular accident) n.s. Intracranial hemorrhage 1 0 n.s. Subdural Hematoma 0 1 n.s. Gastrointestinal Hemorrhage 7 4 n.s. Minor Hemorrhage 10 14 n.s. The Clinical Events During the Usage of New Oral Anticoagulants
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2016.04.095